Diabetic Foot Ulcers - Pipeline Review, H2 2015

1
Diabetic Foot Ulcers - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Diabetic Foot Ulcers
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Diabetic Foot Ulcers
  and enlists all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Diabetic Foot Ulcers products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Diabetic Foot Ulcers pipeline on
  the basis of target, MoA, route of administration
  and molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/diabeti
  c-foot-ulcers-pipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Diabetic Foot Ulcers, H2 2015
12 Number of Products under Development for
Diabetic Foot Ulcers - Comparative Analysis, H2
2015 13 Number of Products under Development by
Companies, H2 2015 14 Comparative Analysis by
Late Stage Development, H2 2015 18 Comparative
Analysis by Clinical Stage Development, H2 2015
19 Comparative Analysis by Early Stage Products,
H2 2015 20 Assessment by Monotherapy Products, H2
2015 53 Number of Products by Top 10 Targets, H2
2015 54 Number of Products by Stage and Top 10
Targets, H2 2015 54 Number of Products by Top 10
Mechanism of Actions, H2 2015 56 Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 56 Number of Products by Top 10
Routes of Administration, H2 2015 58 Number of
Products by Stage and Top 10 Routes of
Administration, H2 2015 58 Number of Products by
Top 10 Molecule Types, H2 2015 60 Number of
Products by Stage and Top 10 Molecule Types, H2
2015 60
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Diabetic Foot Ulcers Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Diabetic Foot Ulcers pipeline depth
and focus of Indication therapeutics Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/diabetic-foot-ulcers-p
ipeline-review-h2-2015-market/enquire-about-report

5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/diabetic-foot-ulcers-p
ipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com